Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Neuronetics (STIM) Shares Outstanding (2016 - 2026)

Neuronetics has reported Shares Outstanding over the past 11 years, most recently at $69.6 million for Q1 2026.

  • Quarterly Shares Outstanding rose 5.72% to $69.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $69.6 million through Mar 2026, up 5.72% year-over-year, with the annual reading at $69.0 million for FY2025, 23.91% up from the prior year.
  • Shares Outstanding was $69.6 million for Q1 2026 at Neuronetics, up from $69.0 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $69.6 million in Q1 2026 and troughed at $26.7 million in Q1 2022.
  • The 5-year median for Shares Outstanding is $30.0 million (2024), against an average of $41.7 million.
  • Year-over-year, Shares Outstanding increased 2.63% in 2022 and then surged 125.76% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $27.3 million in 2022, then rose by 6.69% to $29.1 million in 2023, then skyrocketed by 91.39% to $55.7 million in 2024, then grew by 23.91% to $69.0 million in 2025, then increased by 0.85% to $69.6 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Shares Outstanding are $69.6 million (Q1 2026), $69.0 million (Q4 2025), and $68.4 million (Q3 2025).